Short-term Outcome of Uniportal and Three Portal Video-assisted Thoracic Surgery for Patients with Non-small Cell Lung Cancer.
10.3779/j.issn.1009-3419.2018.12.03
- Author:
Gaoxiang WANG
1
;
Ran XIONG
1
;
Hanran WU
1
;
Guangwen XU
1
;
Caiwei LI
1
;
Xiaohui SUN
1
;
Shibin XU
1
;
Meiqing XU
1
;
Mingran XIE
1
Author Information
1. Department of Thoracic Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.
- Publication Type:Journal Article
- Keywords:
Efficacy;
Lung neoplasms;
Uniportal;
Video-assisted thoracic surgery
- MeSH:
Aged;
Carcinoma, Non-Small-Cell Lung;
pathology;
surgery;
Female;
Humans;
Lung;
pathology;
surgery;
Lung Neoplasms;
pathology;
surgery;
Middle Aged;
Operative Time;
Postoperative Complications;
etiology;
Quality of Life;
Retrospective Studies;
Thoracic Surgery, Video-Assisted;
adverse effects;
methods;
Treatment Outcome
- From:
Chinese Journal of Lung Cancer
2018;21(12):896-901
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Currently, there are many reports on the advantages of three portal video-assisted thoracic surgery (VATS) in the treatment of lung cancer, but there are few reports on the comparison between uniportal and three portal video-assisted thoracic surgery. In this study, we aimed to evaluate the recent curative effect of the postoperative short-term quality of life between uniportal and three portal video-assisted thoracic surgery for non-small cell lung cancer.
METHODS:We retrospectively evaluated 266 patients with NSCLC who underwent intended VATS lobectomy by a single surgical team in our ward between January 2016 and August 2017. The general clinical date, perioperative data and short-term life quality were individually compared and analyzed between the two groups.
RESULTS:The two groups were similar in terms of clinicopathological features, total number of dissected lymph nodes and nodal stations, postoperative complications and pulmonary complications (P>0.05). Compared with three portal VATS, the intraoperative blood loss, chest tube duration, postoperative thoracic drainage, length of stay and NRS score were significantly decreased in uniportal VATS, with significant differences (P<0.05).
CONCLUSIONS:As a more minimally invasive surgery, uniportal VATS can be safely and effectively performed for resectable lung cancer, which would achieve even better operation curative effect than three portal VATS.
